Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Cargo Therapeutics cuts lead CAR-T program, 50% of staff
4 months ago
R&D
Cell/Gene Tx
Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over
4 months ago
Pharma
Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers
4 months ago
Pharma
FDA+
Updated: Zentalis lays off 40% of staff, whittles down indications for WEE1 inhibitor
4 months ago
The RFK question: Trump's HHS nominee splits biopharma before moment of truth
4 months ago
FDA+
Updated: Cell therapy biotech Affini-T Therapeutics reduces staff
4 months ago
Cell/Gene Tx
Exclusive: Leerink builds healthcare M&A team, poaching dealmakers from rivals
4 months ago
Deals
UnitedHealth Group names next insurance CEO, following top executive's murder
4 months ago
Health Tech
Exclusive: Health navigator Quantum Health cuts 4% of workforce
4 months ago
Health Tech
Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’
4 months ago
Exiting Medicare director expects current law to guide next price negotiations
4 months ago
Pharma
FDA+
Departing FDA commissioner: 'We're losing the battle on misinformation'
4 months ago
FDA+
Lykos upheaval continues with four new board exits amid hunt for cash
4 months ago
Financing
Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio
4 months ago
Startups
Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaks
4 months ago
Pharma
Post-Hoc: Big Pharma is losing the AI talent war
4 months ago
AI
Pharma
Updated: CDER Director Patrizia Cavazzoni to step down ahead of Trump presidency
4 months ago
FDA+
Intellia to cut workforce by 27%, plans commercialization of first CRISPR therapy in 2027
4 months ago
Startups
Shoreline cuts staff as its partnership with Gilead's Kite is now in flux
4 months ago
Cell/Gene Tx
IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint
4 months ago
R&D
Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic
4 months ago
Startups
Resilience cuts 120 employees at a former bluebird gene therapy site
4 months ago
Manufacturing
Updated: Galapagos to split into two companies, slash headcount as it eyes turnaround
4 months ago
R&D
Exclusive: Forbion-backed cardio biotech rebrands to RyCarma with Phase 2 plans
4 months ago
Startups
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit